Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro

Pandemic spread of emerging human pathogenic viruses, such as the current SARS-CoV-2, poses both an immediate and future challenge to human health and society. Currently, effective treatment of infection with SARS-CoV-2 is limited and broad spectrum antiviral therapies to meet other emerging pandemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Svenningsen, Esben B., Thyrsted, Jacob, Blay-Cadanet, Julia, Liu, Han, Lin, Shaoquan, Moyano-Villameriel, Jaime, Olagnier, David, Idorn, Manja, Paludan, Søren R., Holm, Christian K., Poulsen, Thomas B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687369/
https://www.ncbi.nlm.nih.gov/pubmed/33248195
http://dx.doi.org/10.1016/j.antiviral.2020.104988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687369/
https://www.ncbi.nlm.nih.gov/pubmed/33248195
http://dx.doi.org/10.1016/j.antiviral.2020.104988

Ejemplares similares